Methylation of PTCH1 Gene in Pancreatic Cancer: A Study in Kashmiri Population

Methylation of PTCH1 Gene in Pancreatic Cancer: A Study in Kashmiri Population

Zeenat Bashir,1 Aabid Ahmad Khanday 2 ,Seema Rani3,

1.                  PG student at Desh Bhagat University Mandi Gobindgarh,  school of paramedical sciences Punjab, India.

2.                  Teaching assistant, Desh Bhagat University Mandi Gobindgarh, Punjab

3.                  Assistant Professor, Desh Bhagat University Mandi Gobindgarh, Punjab

Abstract

Cancer results from a series of molecular events that fundamentally alter the normal properties of cells. In cancer cells the normal control systems that prevent cell overgrowth and the invasion of other tissues are disabled. As these cells grow they develop new characteristics, including changes in cell structure, decreased cell adhesion, and production of new enzymes. These heritable changes allow the cell and its progeny to divide and grow, even in the presence of normal cells that typically inhibit the growth of nearby cells. Such changes allow the cancer cells to spread and invade other tissues (Gibbs et al., 2003). The abnormalities in cancer cells usually result from mutations in protein-encoding genes that regulate cell division. Over time more genes become mutated. This is often because the genes that make the proteins that normally repair DNA damage are themselves not functioning normally because they are also mutated. Consequently, mutations begin to increase in the cell, causing further abnormalities in that cell and the daughter cells. Some of these mutated cells die, but other alterations may give the abnormal cell a selective advantage that allows it to multiply much more rapidly than the normal cells.

KEY WORDS,gene,cancer metastasis,proliferation,exocrine.